The ENEA Tech and Biomedical Foundation, as the lead investor with an investment of 2 million euros and in collaboration...
Harnessing Artificial Intelligence to Unlock the Therapeutic Potential of Plant Bioactives
A Revolutionary Approach to Biodiversity Conservation, Medicinal Discovery, and Sustainable Botanical Production “...
Fighting Glioblastoma: Could CAR-T Cell Therapy Be The Next Frontier?
Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain tumor, making up over 50% of all g...
CAR-Ts sweep into autoimmunity
The promising results and the safety profile demonstrated in preliminary clinical studies are driving several biotech co...
Venture Capital in Biotech: Insights from Giovanni Rizzo (Indaco Venture Partners)
In this interview, Giovanni Rizzo, partner at Indaco Venture Partners, shares his insights on the role of venture capita...
Zoldasiran and Plozasiran – A New future for Familial Combined Hyperlipidemia
Take Home Message Two newly published manuscripts in the New England Journal of Medicine (N Engl J Med) support the effi...